Role of positron emission tomography imaging in myeloid sarcoma

The article by Kanate et al 1 described refractory myeloid sarcoma, which is one of the challenging entities to treat. We congratulate Kanate et al 1 for their excellent report on the role of venetoclax in refractory myeloid sarcoma. This letter is an attempt to discuss the few additional facts with regard to recent advancements in the treatment options for patients with refractory myeloid sarcoma.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Role of positron emission tomography imaging in myeloid sarcoma

Cited by 6 publications

References 4 publications

Temporal region myeloid sarcoma: When to suspect and how to approach?

Temporal region myeloid sarcoma: When to suspect and how to approach?

Testicular Myeloid Sarcoma: A Systematic Review of the Literature

Advancements in Treatment of Refractory and Relapsed Myeloid Sarcoma

Contact Info

Product

Resources

About